Malformation With drug Total OR/RR 95% CI
Any malformation 2206 70317 1.07 1.03-1.12
Rel. severe malformation 1544 45652 1.09 1.03-1.15
Chromosome anomalies 84 2932 1.01 0.81-1.26
Neural tube defect 24 734 1.13 0.75-1.70
Other CNS malformation 31 1131 0.92 0.64-1.32
Severe eye malformation 12 579 0.72 0.41-1.28
Severe ear malformation 4 280 0.45 0.12-1.15#
Cleft lip/palate 44 1704 0.87 0.64-1.57
Median cleft palate 42 1002 1.45 1.06-1.98
Cardiovascular defects 533 16145 1.13 1.04-1.23
Septum defects 144 4380 1.11 0.94-1.31
Esophageal atresia 14 445 1.12 0.66-1.90
Small gut atresia 13 392 1.22 0.70-2.13
Anal atresia 21 590 1.21 0.78-1.87
Pyloric stenosis 46 1101 1.42 1.06-1.91
Abdminal wall defect 10 413 0.84 0.44-1.60
Diaphragmatic hernia 9 368 0.79 0.41-1.52
Hyppospadias 120 4552 0.87 0.73-1.05
Severe renal malformation 26 882 1.00 0.68-1.48
Pes eqinovarus 74 2127 1.14 0.90-1.43
Poly/syndactyly 106 3084 1.21 0.99-1.47
Limb reduction defects 29 838 1.16 0.80-1.68
Craniostenosis 84 812 1.02 0.69-1.51
Rel. severe malformation except a cardiovascular defect 1090 34940 1.07 1.01-1.14
# RR as observed/expected numbers with exact 95% CI.
Table 2: Congenital malformations after any antiasthmatic use. Odds ratio (OR) or risk ratio (RR) with 95% confidence interval (95% CI). Bold text shows statistical significance.